Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (TAHHT)

This study has been completed.
Sponsor:
Collaborators:
Pharmacia GmbH, Erlangen, Germany
Baxter Healthcare Corporation
Information provided by:
University Hospital, Saarland
ClinicalTrials.gov Identifier:
NCT01031992
First received: December 11, 2009
Last updated: December 12, 2009
Last verified: December 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2002
  Primary Completion Date: August 2002 (Final data collection date for primary outcome measure)